Organon Acquires Contraceptive Products, Marvelon® And Mercilon®, In The People’S Republic Of China, Including Hong Kong And Macau, And Agrees To Acquire These Products In Vietnam
Acquiring Company
Organon
Acquired Company
ProductsMarvelon
Jersey City
FranceBiotechnologyHealth CareMedicalDescription
Organon (NYSE: OGN) today announced that it has acquired the rights from Bayer AG to Marvelon® and Mercilon®, combined oral hormonal daily contraceptive pills, in the People’s Republic of China, including Hong Kong and Macau, and has entered into an agreement to acquire the rights to these products in Vietnam. Marvelon and Mercilon are already owned, manufactured, and marketed by Organon as prescription oral contraceptives in 20 other markets. This acquisition gives Organon full global ownership of these brands (except in South Korea) by reacquiring the rights to them in these markets. The agreement to acquire the rights in Vietnam is expected to close in the first half of 2022 and is subject to customary closing conditions, including regulatory approval.
Quick answer
Organon is acquiring ProductsMarvelon and Mercilon, announced February 16, 2022. Organon is based in Jersey City, New Jersey, United States.
- How much did Organon pay for ProductsMarvelon?
- The deal value was not disclosed.
- What does Organon do?
- Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives.
- Where are Organon and ProductsMarvelon based?
- Organon is based in Jersey City, New Jersey, United States.
- Who are the decision-makers at Organon?
- Fundz holds 2 contacts at Organon. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Labcorp Completes Acquisition Of Personal Genome Diagnostics (February 21, 2022)
- Element Biosciences Closes Acquisition Of Loop Genomics (February 8, 2022)
- Intellia Therapeutics Announces Acquisition Of Rewrite Therapeutics (February 3, 2022)
- Im Cannabis Closes Previously Announced Acquisition Of Oranim Pharm, Jerusalem'S Leading Medical Cannabis Pharmacy (March 30, 2022)
- Incannex To Acquire Apirx Pharmaceuticals Usa, Llc (March 24, 2022)
- Emmes Acquires Casimir, Its Fourth Major Acquisition (March 10, 2022)
Who to call at Organon, and when
When Organon changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Organon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Organon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Organon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Organon makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired ProductsMarvelon?
ProductsMarvelon was acquired by Organon, based in Jersey City. The deal was reported on February 16, 2022. Organon is a global healthcare company formed through a spin-off from Merck, (NYSE: MRK) known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Organon is publicly traded (OGN) and operates in Biotechnology.
When did Organon acquire ProductsMarvelon?
Organon's acquisition of ProductsMarvelon was reported on February 16, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ProductsMarvelon do?
ProductsMarvelon is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.